HCP
SRDX

Hardin Capital Partners’s Surmodics SRDX Stock Holding History

Hardin Capital Partners’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,900
Closed -$206K – 120
2024
Q2 		$206K Buy
+4,900
New +$167K 0.13% 113

Other funds holding SRDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hardin Capital Partners's SRDX Position: Q3 2024 in Review

Hardin Capital Partners sold out of Surmodics (SRDX) in Q3 2024, closing a stake of 4,900 shares — an estimated $206K sold.

Hardin Capital Partners first reported a position in SRDX in Q2 2024 and held it in 1 quarter. The position peaked at $206K in Q2 2024. 127 funds tracked by Wall St. Rank hold SRDX as of Q3 2024.

  • Hardin Capital Partners reported no remaining Surmodics position as of Q3 2024 after selling out during the quarter.
  • Hardin Capital Partners sold 4,900 Surmodics shares in Q3 2024, an estimated $206K.
  • Hardin Capital Partners first reported a position in Surmodics in Q2 2024 and held it in 1 quarter.
  • Hardin Capital Partners's Surmodics position peaked at $206K in Q2 2024.
  • 127 funds tracked by Wall St. Rank held Surmodics as of Q3 2024.

Based on Hardin Capital Partners's 13F filing for Q3 2024, filed 18 Oct 2024.